CD8α+ dendritic cells prime TCR-peptide-reactive regulatory CD4+FOXP3- T cells

European Journal of Immunology

Volumn 40, Issue 7, 2010, Pages 1906-1915

  Smith, Trevor R F ^a   Maricic, Igor ^a   Ria, Francesco ^b   Schneider, Susan ^b   Kumar, Vipin ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Antigen presentation processing; DC; EAE MS; TCR; Tolerance suppression anergy

Indexed keywords

CD8ALPHA ANTIGEN; TRANSCRIPTION FACTOR FOXP3; CD4 ANTIGEN; CD8 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; MYELIN BASIC PROTEIN; PEPTIDE FRAGMENT; T CELL RECEPTOR VBETA8; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; CELL CLONE; HUMAN; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE STRAIN; PATHOLOGY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD4; ANTIGENS, CD8; APOPTOSIS; CLONE CELLS; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, REGULATORY;

EID: 77954129089     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939608     Document Type: Article

References (47)

1. Sakaguchi, S.,Wing, K. and Miyara, M., Regulatory T cells - a brief history and perspective. Eur. J. Immunol. 2007. 37: S116-S123.
2. Shevach, E. M., Regulatory T cells in autoimmmunity*. Annu. Rev. Immunol. 2000. 18: 423-449.
3. Kumar, V., Homeostatic control of immunity by TCR peptide-specific Tregs. J. Clin. Invest. 2004. 114: 1222-1226.
4. Godfrey, D. I. and Kronenberg, M., Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004. 114: 1379-1388.
5. Arrenberg, P., Halder, R. and Kumar, V., Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J. Cell Physiol. 2009. 218: 246-250.
6. Kumar, V. and Sercarz, E. E., The involvement of T cell receptor peptide-specific regulatory CD4+T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 1993. 178: 909-916.
7. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. and Roncarolo, M. G., A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737-742.
8. Piccirillo, C. A., Tritt, M., Sgouroudis, E., Albanese, A., Pyzik, M. and Hay, V., Control of type 1 autoimmune diabetes by naturally occurring CD4+ CD25+regulatory T lymphocytes in neonatal NOD mice. Ann. N. Y. Acad. Sci. 2005. 1051: 72-87.
9. Viglietta, V., Baecher-Allan, C., Weiner, H. L. and Hafler, D. A., Loss of functional suppression by CD4+CD25+regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004. 199: 971-979.
10. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A. and Mauri, C., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004. 200: 277-285.
11. Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M. and Tree, T. I., Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005. 54: 92-99.
12. Read, S., Malmstrom, V. and Powrie, F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000. 192: 295-302.
13. Nakamura, K., Kitani, A. and Strober, W., Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 2001. 194: 629-644.
14. Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., al-Sabbagh, A., Santos, L., Sayegh, M. et al., Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 1994. 12: 809-837.
15. Madakamutil, L. T., Maricic, I., Sercarz, E. and Kumar, V., Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J Immunol. 2003. 170: 2985-2992. (Pubitemid 36302171)
16. Kumar, V., Aziz, F., Sercarz, E. and Miller, A., Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis. J. Exp. Med. 1997. 185: 1725-1733.
17. Kumar, V., Stellrecht, K. and Sercarz, E., Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J. Exp. Med. 1996. 184: 1609-1617. (Pubitemid 26404454)
18. Tang, X., Maricic, I. and Kumar, V., Anti-TCR antibody treatment activates a novel population of nonintestinal CD8 alpha alpha+TCR alpha beta+regulatory T cells and prevents experimental autoimmune encephalomyelitis. J. Immunol. 2007. 178: 6043-6050. (Pubitemid 46717383)
19. Tang, X., Maricic, I., Purohit, N., Bakamjian, B., Reed-Loisel, L. M., Beeston, T., Jensen, P. and Kumar, V., Regulation of immunity by a novel population of Qa-1-restricted CD8alphaalpha+TCRalphabeta+T cells. J. Immunol. 2006. 177: 7645-7655.
20. Tabi, Z., McCombe, P. A. and Pender, M. P., Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int. Immunol. 1995. 7: 967-973.
21. Schmied, M., Breitschopf, H., Gold, R., Zischler, H., Rothe, G., Wekerle, H. and Lassmann, H., Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 1993. 143: 446-452.
22. Peng, Y., Martin, D. A., Kenkel, J., Zhang, K., Ogden, C. A. and Elkon, K. B., Innate and adaptive immune response to apoptotic cells. J. Autoimmun. 2007. 29: 303-309.
23. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M. et al., Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 1998. 188: 2163-2173.
24. Smith, T. R., Tang, X., Maricic, I., Garcia, Z., Fanchiang, S. and Kumar, V., Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphalpha+TCRalphabeta+T cells with regulatory properties. J. Immunol. 2009.182: 6959-6968.
25. Kumar, V., Tabibiazar, R., Geysen, H. M. and Sercarz, E., Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 1995. 154: 1941-1950.
26. Albert, M. L., Sauter, B. and Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998. 392: 86-89.
27. Yasumi, T., Katamura, K., Okafuji, I., Yoshioka, T., Meguro, T. A., Nishikomori, R., Kusunoki, T. et al., Limited ability of antigen-specific Th1 responses to inhibit Th2 cell development in vivo. J. Immunol. 2005. 174: 1325-1331.
28. Maldonado-Lopez, R., De, S. T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K. et al., CD8alpha+and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 1999. 189: 587-592.
29. Braciak, T. A., Pedersen, B., Chin, J., Hsiao, C., Ward, E. S., Maricic, I., Jahng, A. et al., Protection against experimental autoimmune encephalomyelitis generated by a recombinant adenovirus vector expressing the V beta 8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10. J. Immunol. 2003. 170: 765-774.
30. Smith, T. R. and Kumar, V., Revival of CD8(+) Treg-mediated suppression. Trends Immunol. 2008. 29: 337-342.
31. Lider, O., Reshef, T., Beraud, E., Ben-Nun, A. and Cohen, I. R., Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 1988. 239: 181-183. (Pubitemid 18026682)
32. Zhang, J., Medaer, R., Stinissen, P., Hafler, D. and Raus, J., MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993. 261: 1451-1454.
33. Vandenbark, A. A., Hashim, G. and Offner, H., Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989. 341: 541-544.
34. Howell, M. D., Winters, S. T., Olee, T., Powell, H. C., Carlo, D. J. and Brostoff, S. W., Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989. 246: 668-670.
35. Steinman, R. M. and Nussenzweig, M. C., Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 2002. 99: 351-358.
36. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A. H., Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000. 192: 1213-1222.
37. Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K. and Steinman, R. M., Direct expansion of functional CD25+CD4+regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003. 198: 235-247.
38. Wang, L., Pino-Lagos, K., de Vries, V. C., Guleria, I., Sayegh, M. H. and Noelle, R. J., Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+regulatory T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 9331-9336.
39. Moody, D. B. and Porcelli, S. A., Intracellular pathways of CD1 antigen presentation. Nat. Rev. Immunol. 2003. 3: 11-22.
40. Roy, K. C., Maricic, I., Khurana, A., Smith, T. R., Halder, R. C. and Kumar, V., Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells. J. Immunol. 2008. 180: 2942-2950.
41. Bevan, M. J., Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 2004. 4: 595-602.
42. Wilson, E. B. and Livingstone, A. M., Cutting edge: CD4+T cell-derived IL-2 is essential for help-dependent primary CD8+T cell responses. J. Immunol. 2008. 181: 7445-7448.
43. Steinman, R. M., Turley, S., Mellman, I. and Inaba, K., The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000. 191: 411-416.
44. Steinman, R. M. and Banchereau, J., Taking dendritic cells into medicine. Nature 2007. 449: 419-426.
45. Koh, D. R., Fung-Leung, W. P., Ho, A., Gray, D., cha-Orbea, H. and Mak, T. W., Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 1992. 256: 1210-1213.
46. Clark-Lewis, I., Aebersold, R., Ziltener, H., Schrader, J. W., Hood, L. E. and Kent, S. B., Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3. Science 1986. 231: 134-139. (Pubitemid 16154700)
47. Kumar, V., Bhardwaj, V., Soares, L., Alexander, J., Sette, A. and Sercarz, E., Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. Proc. Natl. Acad. Sci. USA 1995. 92: 9510-9514.